Compounds > angiotensin ii, des-phe(8)-
Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Angiogenesis, Pathologic

angiotensin ii, des-phe(8)- has been researched along with Angiogenesis, Pathologic in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (23.08)29.6817
2010's10 (76.92)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Sun, Y; Zhao, T; Zhao, W1
Abd-Alhaseeb, MM; Abou-El-Ela, SH; Moustafa, YM; Zaitone, SA1
Cai, SM; Li, X; Li, Y; Ning, ZW; Zhang, LL; Zhang, WY1
Jarajapu, YP; Pawar, R; Singh, N; Vasam, G1
Chen, Y; Hao, P; Li, B; Li, G; Liu, Y; Shang, R; Wang, J; Wang, X; Yang, J; Zhang, C; Zhang, M; Zhang, Y1
Chen, B; Chen, X; Du, H; Katovich, MJ; Li, A; Li, H; Li, J; Pei, N; Qi, Y; Sumners, C; Wan, R; Wei, W; Zhang, Y; Zheng, H1
Bai, N; Chen, B; Chen, S; Chen, X; Du, H; Li, A; Li, H; Li, J; Mao, Y; Pei, N; Sumners, C; Wang, S; Yan, R; Zhang, Y1
Gallagher, PE; Menon, J; Soto-Pantoja, DR; Tallant, EA1
Ager, EI; Chan, J; Chong, WW; Christophi, C; Neo, JH; Wen, SW1
Fan, L; Feng, Y; Gao, B; Li, Q; Ma, Q; Ni, L; Qian, Y; Wan, H; Xiang, Y1
Gallagher, PE; Krishnan, B; Tallant, EA; Torti, FM1
Wilkinson-Berka, JL1
Andrade, SP; Machado, RD; Santos, RA1

Reviews

1 review(s) available for angiotensin ii, des-phe(8)- and Angiogenesis, Pathologic

ArticleYear
Angiotensin and diabetic retinopathy.
    The international journal of biochemistry & cell biology, 2006, Volume: 38, Issue:5-6

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Genetically Modified; Diabetic Retinopathy; Humans; Hypertension; Neovascularization, Pathologic; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Retina

2006

Other Studies

12 other study(ies) available for angiotensin ii, des-phe(8)- and Angiogenesis, Pathologic

ArticleYear
Angiotensin 1-7 promotes cardiac angiogenesis following infarction.
    Current vascular pharmacology, 2015, Volume: 13, Issue:1

    Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Female; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Vascular Endothelial Growth Factor D; Ventricular Remodeling

2015
Olmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7).
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Female; Imidazoles; Immunohistochemistry; Insulin-Like Growth Factor I; Mice; Neovascularization, Pathologic; Niacinamide; Peptide Fragments; Phenylurea Compounds; Receptor, IGF Type 1; Sorafenib; Tetrazoles; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2014
[Inhibitory effect of angiotensin (1-7) on hepatic sinusoid angiogenesis in bile duct ligation-induced hepatic fibrosis of rats].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2013, Volume: 21, Issue:12

    Topics: Angiotensin I; Animals; Bile Ducts; Hepatic Veins; Ligation; Liver Cirrhosis, Experimental; Male; Neovascularization, Pathologic; Peptide Fragments; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A; von Willebrand Factor

2013
Angiotensin-(1-7) reverses angiogenic dysfunction in corpus cavernosum by acting on the microvasculature and bone marrow-derived cells in diabetes.
    The journal of sexual medicine, 2014, Volume: 11, Issue:9

    Topics: Angiotensin I; Animals; Bone Marrow Cells; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Flow Cytometry; Male; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Penis; Peptide Fragments; Proto-Oncogene Mas; Real-Time Polymerase Chain Reaction; Vascular Endothelial Growth Factor A

2014
Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor.
    Molecular medicine (Cambridge, Mass.), 2015, Jul-27, Volume: 21

    Topics: Angiotensin I; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mitogen-Activated Protein Kinase 11; Neovascularization, Pathologic; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Xenograft Model Antitumor Assays

2015
Angiotensin-(1-7) Decreases Cell Growth and Angiogenesis of Human Nasopharyngeal Carcinoma Xenografts.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:1

    Topics: Angiogenesis Inhibitors; Angiotensin I; Animals; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; MAP Kinase Signaling System; Membrane Proteins; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neovascularization, Pathologic; Peptide Fragments; Proto-Oncogene Mas; Receptors, Vascular Endothelial Growth Factor; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2016
AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivo.
    Oncotarget, 2017, Jan-03, Volume: 8, Issue:1

    Topics: Angiotensin I; Animals; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dependovirus; DNA Replication; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Genetic Vectors; Humans; Immunohistochemistry; Lung; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Multienzyme Complexes; Neovascularization, Pathologic; Nuclear Proteins; Peptide Fragments; Proteolysis; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2017
Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor.
    Molecular cancer therapeutics, 2009, Volume: 8, Issue:6

    Topics: Angiotensin I; Animals; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Chick Embryo; Chorioallantoic Membrane; Endothelial Cells; Humans; Injections, Subcutaneous; Lung Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2009
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
    BMC cancer, 2011, Jun-26, Volume: 11

    Topics: Adenocarcinoma; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers, Tumor; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Irbesartan; Liver Neoplasms, Experimental; Mice; Mice, Inbred CBA; Molecular Targeted Therapy; Neoplasm Proteins; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Tumor Burden; Up-Regulation; Vascular Endothelial Growth Factor A

2011
Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways.
    Oncology reports, 2012, Volume: 27, Issue:3

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Angiotensin I; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Renin-Angiotensin System; Signal Transduction; Survival

2012
Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.
    The Prostate, 2013, Volume: 73, Issue:1

    Topics: Adenocarcinoma; Angiotensin I; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Peptide Fragments; Placenta Growth Factor; Pregnancy Proteins; Prostatic Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Xenograft Model Antitumor Assays

2013
Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 280, Issue:4

    Topics: Analysis of Variance; Angiogenesis Inhibitors; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Imidazoles; Losartan; Male; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Prostheses and Implants; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2

2001